Indigo Agriculture opens European headquarters in Basel
Indigo Agriculture is expanding to Europe and has opened headquarters in Basel to this end. The U.S. company offers pioneering technologies for the agricultural sector. BaselArea.swiss supported Indigo in relocating to Basel.
How can the quality of wheat be tested? (img: pixabay)
Indigo is opening offices in Basel, from where the company’s European business will be managed, as was reported in a press release. Heading up the Europe segment is Georg Goeres, who was previously responsible for commercial operations and strategy at Basel agrochemical company Syngenta.
Founded in 2013, the company from Boston develops pioneering technologies for the agricultural sector. These include microbiotechnology for seed treatments, techniques for soil sampling, grain quality testing, remote sensing and analytics as well as a digital marketplace for grain transactions.
Indigo has as its objective to work together with farmers and various interest groups in Europe. The aim is to further optimize the supply chain in farming and offer consumers traceable and nutritious products. In future, Indigo intends to get European farmers on board for Indigo Carbon, a program to accelerate carbon sequestration from agricultural soil. It supplements the Terraton Initiative, a global project to remove one trillion metric tons of carbon dioxide from the Earth’s atmosphere and use it to enrich agricultural soils.
„Indigo is leading the movement towards beneficial agriculture. That makes it the most exciting company I have been a part of in my 25-year career,“ commented Georg Goeres.
BaselArea.swiss supported Indigo in relocating to Basel.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More
The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.Read More